What we do
It’s not enough for a drug to simply exist. To change the world, it must be accessible to everyone. As a group, Univercells develops breakthrough technologies and services that democratize the production of biologics.
So that everyone, everywhere has access to the medicines they need, when they need them.

Mission & Vision
Univercells is committed to revolutionizing the availability of biologics around the world, by making essential medicines affordable to all, in both quality and price.
How? Via a diversified and synergistic portfolio of companies with different maturities and impact on the health value chain.
Univercells global remarkable network is its net worth
CAMPUS OF COMPANIES
We operate as a campus of start-ups. Six businesses solving the different parts of the same puzzle, namely meeting global demand for bioproduction.
Technology
Cutting-edge, scalable technology portfolio to enable partners to achieve low-cost, low-footprint, high-quality and high-performance production. Applications in RNA, DNA and viral production from R&D to commercial.
RNA

CDMO
Designing and operating bespoke bioproduction hubs with state-of-the-art technology which includes proprietary biomanufacturing technologies. Offer preclinical to commercial GMP capabilities and expertise for innovators in advanced therapies and vaccines.

Advisory
Turnkey services to support emerging players wherever biologics can make a difference, making local bioproduction a reality. Offering spans from design to operations of bioproduction sites which includes technology transfer, training, and regulatory affairs.


Our History
Univercells was created in Belgium in 2013 with one mission: making biologics available to all. Discover how the company and team has grown and continues to evolve closer to that goal.